These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5000053)

  • 1. On the intracerebral origin of homovanillic acid of the cerebrospinal fluid of experimental animals.
    Papeschi R; Sourkes TL; Poirier LJ; Boucher R
    Brain Res; 1971 May; 28(3):527-33. PubMed ID: 5000053
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome.
    Johansson B; Roos BE
    Life Sci; 1967 Jul; 6(13):1449-54. PubMed ID: 6035772
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental midbrain lesions: neurochemical comparison between the animal model and Parkinson's disease.
    Hockman CH; Lloyd KG; Farley IJ; Hornykiewicz O
    Brain Res; 1971 Dec; 35(2):613-8. PubMed ID: 5135560
    [No Abstract]   [Full Text] [Related]  

  • 4. The nigrostriatal pathway: a correlative study based on neuroanatomical and neurochemical criteria in the cat and the monkey.
    Bédard P; Larochelle L; Parent A; Poirier LJ
    Exp Neurol; 1969 Nov; 25(3):365-77. PubMed ID: 4981857
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor.
    Fahn S; Libsch LR; Cutler RW
    J Neurol Sci; 1971 Dec; 14(4):427-55. PubMed ID: 5125758
    [No Abstract]   [Full Text] [Related]  

  • 6. The release in vivo of dopamine synthesized from labelled precursors in the caudate nucleus of the cat.
    Riddell D; Szerb JC
    J Neurochem; 1971 Jun; 18(6):989-1006. PubMed ID: 4398120
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
    Garelis E; Young SN; Lal S; Sourkes TL
    Brain Res; 1974 Oct; 79(1):1-8. PubMed ID: 4279131
    [No Abstract]   [Full Text] [Related]  

  • 8. A quantitative study on the nigro-neostriatal dopamine neuron system in the rat.
    Andén NE; Hfuxe K; Hamberger B; Hökfelt T
    Acta Physiol Scand; 1966; 67(3):306-12. PubMed ID: 5967596
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo continuous estimation of 3 H-dopamine synthesis and release in the cat caudate nucleus. Effects of -methyl-p-tyrosine and of transection of the nigro neostriatal pathway.
    Besson MJ; Cheramy A; Gauchy C; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):101-5. PubMed ID: 4267960
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of chronically administered L-dopa in normal and lesioned cats.
    Langelier P; Roberge AG; Boucher R; Poirier LJ
    J Pharmacol Exp Ther; 1973 Oct; 187(1):15-26. PubMed ID: 4746324
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinson's disease: from brain homogenate to treatment.
    Hornykiewicz O
    Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA; Dowson JH; Ahmed R; Chow R; Gillingham FJ
    Confin Neurol; 1972; 34(1):143-8. PubMed ID: 5084388
    [No Abstract]   [Full Text] [Related]  

  • 13. Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor.
    Rinne UK; Sonninen V
    Arch Neurol; 1973 Feb; 28(2):107-10. PubMed ID: 4683147
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation.
    Bunney BS; Aghajanian GK
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():249-67. PubMed ID: 826996
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of amines in the striatum in monkeys with nigral lesions. The disposition, biosynthesis and metabolites of [3H]dopamine and [14C]serotonin in the striatum.
    Goldstein M; Anagnoste B; Battista AF; Owen WS; Nakatani S
    J Neurochem; 1969 Apr; 16(4):645-53. PubMed ID: 4976670
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo release of transmitters in the cat basal ganglia.
    Glowinski J
    Fed Proc; 1981 Feb; 40(2):135-41. PubMed ID: 6161843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 18. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.
    Moir AT; Ashcroft GW; Crawford TB; Eccleston D; Guldberg HC
    Brain; 1970; 93(2):357-68. PubMed ID: 4912291
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine and extrapyramidal motor function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():390-415. PubMed ID: 4561070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.